Urologix Inc.
Stock Exchange Other OTC
EPS
-
Market Cap
$24 K
Shares Outstanding
21.82 M
Public Float
-

Profile

Address
14405 21st Avenue North
Minneapolis Minnesota 55447
United States
Employees -
Website -
Updated 07/08/2019
Urologix, Inc. develops, manufactures, markets and distributes minimally invasive medical products for the treatment of obstruction and symptoms due to Benign Prostatic Hyperplasia. The company was founded by Mitchell Dann and John M. Reid on May 29, 1991 and is headquartered in Minneapolis, MN.

Financials

View All

Mitchell Dann
Chairman
Chip Emery
Independent Director